Blood cell differential count discretisation modelling to predict survival in adults reporting to the emergency room: a retrospective cohort study

Abstract

ObjectivesTo assess the survival predictivity of baseline blood cell differential count (BCDC), discretised according to two different methods, in adults visiting an emergency room (ER) for illness or trauma over 1 year.DesignRetrospective cohort study of hospital records.SettingTertiary care public hospital in northern Italy.Participants11 052 patients aged >18 years, consecutively admitted to the ER in 1 year, and for whom BCDC collection was indicated by ER medical staff at first presentation.Primary outcomeSurvival was the referral outcome for explorative model development. Automated BCDC analysis at baseline assessed haemoglobin, mean cell volume (MCV), red cell distribution width (RDW), platelet distribution width (PDW), platelet haematocrit (PCT), absolute red blood cells, white blood cells, neutrophils, lymphocytes, monocytes, eosinophils, basophils and platelets. Discretisation cut-offs were defined by benchmark and tailored methods. Benchmark cut-offs were stated based on laboratory reference values (Clinical and Laboratory Standards Institute). Tailored cut-offs for linear, sigmoid-shaped and U-shaped distributed variables were discretised by maximally selected rank statistics and by optimal-equal HR, respectively. Explanatory variables (age, gender, ER admission during SARS-CoV2 surges and in-hospital admission) were analysed using Cox multivariable regression. Receiver operating curves were drawn by summing the Cox-significant variables for each method.ResultsOf 11 052 patients (median age 67 years, IQR 51–81, 48% female), 59% (n=6489) were discharged and 41% (n=4563) were admitted to the hospital. After a 306-day median follow-up (IQR 208–417 days), 9455 (86%) patients were alive and 1597 (14%) deceased. Increased HRs were associated with age >73 years (HR=4.6, 95% CI=4.0 to 5.2), in-hospital admission (HR=2.2, 95% CI=1.9 to 2.4), ER admission during SARS-CoV2 surges (Wave I: HR=1.7, 95% CI=1.5 to 1.9; Wave II: HR=1.2, 95% CI=1.0 to 1.3). Gender, haemoglobin, MCV, RDW, PDW, neutrophils, lymphocytes and eosinophil counts were significant overall. Benchmark-BCDC model included basophils and platelet count (area under the ROC (AUROC) 0.74). Tailored-BCDC model included monocyte counts and PCT (AUROC 0.79).ConclusionsBaseline discretised BCDC provides meaningful insight regarding ER patients’ survival.

The ‘analysis of gene expression and biomarkers for point-of-care decision support in Sepsis‘ study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination

“…NLR is a well-documented feature of many severe inflammatory conditions including sepsis ( 76 ), heart failure and other conditions ( 77 ), trauma ( 78 , 79 ) and cardiac arrest ( 80 – 83 ) and is indicative of a poor outcome. Elevated neutrophil and reduced lymphocyte counts have been associated with poor outcomes in emergency medicine in general ( 84 ). The NLR response in sepsis is irrespective of age as it is also observed in neonatal sepsis ( 85 , 86 ).…”

The Laboratory Perspective of Leukocyte Differential, Lymphocyte Count and Cell Population Data in Evaluation of Sarscov2: A Comprehensive Systematic Review

“…Fumagalli, et al 8 (2023) explored factors influencing COVID-19 survival outcomes. They analyzed a range of blood cell characteristics, including leukocyte count and lymphocyte count, along with demographic factors like age, gender, and hospital admissions.…”